1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Erythrodermic Psoriasis: new trials by email Literature Review of Erythrodermic Psoriasis trials Research Report on Erythrodermic Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis Ixekizumab - Generalized Pustular Psoriasis, Erythrodermic Psoriasis | Phase 4 | Completed | Eli Lilly and Company | 12 | 2019-07-05 | 2021-08-13 |
Psoriasis (1)
Skin Diseases (1) · Skin Diseases, Papulosquamous (1) · Skin and Connective Tissue Diseases (1)
ixekizumab (1)
Japan (1)